资讯

Correlation of drug-induced and drug-related ultra-high performance liquid chromatography-mass spectrometry serum metabolomic profiles yields discovery of effective constituents of Sini decoction ...
Dabigatran etexilate is a pro-drug, undergoing rapid ester hydrolysis to its active moiety, dabigatran, with no significant CYP 450 metabolism. 1,115 After oral administration, plasma concentrations ...
DNA adducts are a measure of internal exposure to genotoxicants and an important biomarker for human risk assessment. However, the employment of DNA adducts as biomarkers in human studies is often ...
Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.
At WWDC 2025, the company announced a refreshed user interface called Liquid Glass, which features shiny, reflective, and transparent visual interface elements that give the software a more ...
7) Salvarsan -- The Cure for Lust. Chances are, Salvarsan didn't make your list of most important drugs. But historians Swann and Greenberg say it belongs in the club.
Travelers have long been accustomed to packing liquids in their carry-on bags according to the TSA liquid limit, also known as the 3-1-1 rule.. Created by explosive experts after a thwarted plot ...
Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to ...
A former member of police staff has been jailed for passing confidential information to her drug dealer boyfriend. An investigation by South Wales Police found Lucy Langmead, 44, from Pontypridd ...
The drugs are already being investigated as treatments for certain muscle- or bone-related conditions, but Regeneron reasoned that they could also be used to proactively prevent muscle loss while ...
Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.
"In patients with heavily pretreated, advanced gastric or gastroesophageal junction cancer who have extremely limited treatment options and poor prognosis, satri-cel has demonstrated breakthrough ...